Bioadvise ApS: Financial statements 2025
CVR: 39920034
Source: annual report 2025, Danish Business Authority
01/01/2025 – 31/12/2025
Bioadvise ApS (CVR 39920034) has filed annual accounts for 2025. In 2025, the company reported a gross profit of DKK 0 and a net result of DKK 0 compared with DKK -210,600 the year before. Equity in the 2025 report amounted to DKK -34,634.
- Gross Profit
- DKK 0
- Profit/Loss
- DKK 0
- Equity
- DKK -34,634
- Total Assets
- DKK 0
- Employees
- 0
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2025 | - | 0 | 0 | -35 t. | 0 |
| 2024 | - | -11 t. | -211 t. | -35 t. | 0 |
| 2023 | - | 0 | -29 t. | 176 t. | 0 |
| 2022 | - | -154 t. | -176 t. | 205 t. | 0 |
| 2021 | - | 122 t. | 53 t. | 381 t. | 0 |
Official annual report
How creditworthy is Bioadvise ApS?
See the CDS score and get a full credit report with recommended credit limit and payment terms.
Read about the CDS scoreEvents in 2025
Bioadvise ApS has published its annual report for 2024. Gross profit came to DKK -10,620, and the net result was DKK -210,600.
About Bioadvise ApS
Bioadvise ApS was a Danish company of the type Anpartsselskab based in Kongens Lyngby, founded in 2018. The company has been dissolved on 21 September 2026. The company was registered under the industry Forskning og eksperimentel udvikling inden for naturvidenskab og teknik. The company was previously named Bioadvise IVS. The company has 1 employee (2020). In 2025, the company reported a gross profit of DKK 0 and a net result of DKK 0 compared with DKK -210,600 the year before. Equity in the 2025 report amounted to DKK -34,634.